Compare Vertex Pharmaceuticals Incorporated (VRTX) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vertex Pharmaceuticals Incorporated vs 22nd Century Group Inc — how do they compare? Vertex Pharmaceuticals Incorporated trades at $481.09 (market cap $121.95B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 81845.6× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.
| VRTX | XXII | |
|---|---|---|
Market Cap | $121.95B | $1.49M |
Sector | Health | Technology |
52-Week High | $529.59 | $1.07K |
52-Week Low | $366.54 | $3.90 |
Enterprise Value | $116.69B | -$6.74M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
